<DOC>
	<DOCNO>NCT01023789</DOCNO>
	<brief_summary>The ABSORB EXTEND trial continue assessment safety performance ABSORB Bioresorbable Vascular Scaffold ( BVS ) System ABSORB BVS currently development Abbott Vascular .</brief_summary>
	<brief_title>ABSORB EXTEND Clinical Investigation</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<criteria>Up two de novo lesion treat , locate separate native epicardial vessel . Target lesion ( ) must locate native coronary artery target vessel ( ) diameter ≥ 2.0 mm ≤ 3.3 mm target lesion length ≤ 28 mm , assess online QCA . Target lesion ( ) must major artery branch visually estimate stenosis ≥ 50 % &lt; 100 % TIMI flow ≥ 1 . If two treatable lesion meet inclusion criterion must separate major epicardial vessel ( LAD septal diagonal branch , LCX obtuse marginal and/or ramus intermedius branch RCA branch ) . Percutaneous intervention lesion nontarget vessel allow do ≥ 30 day prior plan do 6 month index procedure . Percutaneous intervention lesion target vessel allow do &gt; 6 month prior plan do 6 month index procedure . Lesion ( ) locate within arterial saphenous vein graft distal diseased ( defined vessel irregularity per angiogram &gt; 20 % stenosed lesion visual estimation ) arterial saphenous vein graft . Lesion ( ) involve bifurcation side branch vessel ≥ 2 mm diameter and/or ostial lesion &gt; 40 % stenosed visual estimation side branch require predilatation . Total occlusion ( TIMI flow 0 ) , prior wire passing . Target vessel ( ) contain visible thrombus . Another clinically significant lesion locate epicardial vessel ( include side branch ) target lesion ( ) . Subject receive brachytherapy epicardial vessel ( include side branch ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Drug elute stent</keyword>
	<keyword>Stents</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Bioabsorbable</keyword>
	<keyword>Bioresorbable</keyword>
	<keyword>Scaffold</keyword>
</DOC>